On Validating Multimodal MRI Based Stratification of IDH Genotype in High Grade Gliomas Using CNNs and Its Comparison to Radiomics

2020 ◽  
pp. 53-60 ◽  
Author(s):  
Tanay Chougule ◽  
Sumeet Shinde ◽  
Vani Santosh ◽  
Jitender Saini ◽  
Madhura Ingalhalikar
Keyword(s):  
High Grade ◽  
Multimodal Mri ◽  
High Grade Gliomas

scholarly journals Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas

2019 ◽  
Vol 142 (2) ◽  
pp. 299-307 ◽  
Author(s):  
Hao Zhou ◽  
Ken Chang ◽  
Harrison X. Bai ◽  
Bo Xiao ◽  
Chang Su ◽  
...  
Keyword(s):  
Machine Learning ◽  
Isocitrate Dehydrogenase ◽  
High Grade ◽  
Multimodal Mri ◽  
High Grade Gliomas

scholarly journals Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas

2016 ◽  
Vol 19 (1) ◽  
pp. 109-117 ◽  
Author(s):  
Biqi Zhang ◽  
Ken Chang ◽  
Shakti Ramkissoon ◽  
Shyam Tanguturi ◽  
Wenya Linda Bi ◽  
...  
Keyword(s):  
Isocitrate Dehydrogenase ◽  
High Grade ◽  
Mri Features ◽  
Multimodal Mri ◽  
High Grade Gliomas

Illustration of the Added Value of 18F-DOPA PET to Multimodal MRI to Distinguish Low- and High-Grade Gliomas

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Nicolas Louarn ◽  
Paul Kauv ◽  
Laurent Capelle ◽  
Karima Mokhtari ◽  
Emmanuel Itti
Keyword(s):  
Added Value ◽  
High Grade ◽  
Multimodal Mri ◽  
High Grade Gliomas

Venous Thromboembolism and High Grade Gliomas

1993 ◽  
Vol 70 (03) ◽  
pp. 393-396 ◽  
Author(s):  
Mandeep S Dhami ◽  
Robert D Bona ◽  
John A Calogero ◽  
Richard M Hellman
Keyword(s):  
Risk Factors ◽  
Venous Thromboembolism ◽  
Medical Center ◽  
Significant Risk ◽  
Bleeding Complications ◽  
Fisher Exact Test ◽  
High Grade ◽  
Chi Square ◽  
Exact Test ◽  
High Grade Gliomas

SummaryA retrospective study was done to determine the incidence of and the risk factors predisposing to clinical venous thromboembolism (VTE) in patients treated for high grade gliomas. Medical records of 68 consecutive patients diagnosed and treated at Saint Francis Hospital and Medical Center from January 1986 to June 1991 were reviewed. The follow up was to time of death or at least 6 months (up to December 1991). All clinically suspected episodes of VTE were confirmed by objective tests. Sixteen episodes of VTE were detected in 13 patients for an overall episode rate of 23.5%. Administration of chemotherapy (p = 0.027, two tailed Fisher exact test) and presence of paresis (p = 0.031, two tailed Fisher exact test) were statistically significant risk factors for the development of VTE. Thrombotic events were more likely to occur in the paretic limb and this difference was statistically significant (p = 0.00049, chi square test, with Yates correction). No major bleeding complications were seen in the nine episodes treated with long term anticoagulation.We conclude that venous thromboembolic complications are frequently encountered in patients being treated for high grade gliomas and the presence of paresis and the administration of chemotherapy increases the risk of such complications.

Sign in / Sign up

Export Citation Format

Share Document